These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 7829409

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J, Mormède M, Fourche J, Bébéar C.
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis.
    Hoffner SE, Gezelius L, Olsson-Liljequist B.
    J Antimicrob Chemother; 1997 Dec; 40(6):885-8. PubMed ID: 9462443
    [Abstract] [Full Text] [Related]

  • 6. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S, Pellegrin JL, Leblanc F, Fourche J, Maugein J.
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Susceptibility of Mycobacterium kansasii to ofloxacin, sparfloxacin, clarithromycin, azithromycin, and fusidic acid.
    Witzig RS, Franzblau SG.
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1997-9. PubMed ID: 8239620
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M, Gutierrez J, Ruiz P, Moreno G.
    Chemotherapy; 1995 Sep; 41(3):204-7. PubMed ID: 7656667
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [In vitro antimycobacterial activity of a new quinolone, NM394].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [Abstract] [Full Text] [Related]

  • 19. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
    Gorzynski EA, Gutman SI, Allen W.
    Antimicrob Agents Chemother; 1989 Apr; 33(4):591-2. PubMed ID: 2524998
    [Abstract] [Full Text] [Related]

  • 20. In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).
    Saito H, Sato K, Tomioka H, Dekio S.
    Tuber Lung Dis; 1995 Oct; 76(5):377-80. PubMed ID: 7495996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.